Aster DM Healthcare Ltd
Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. #
Portfolio
The company has a network of 26 hospitals out of which 13 are situated in Gulf Council Corporation (GCC) and the rest 13 are situated in India. It has an installed capacity of ~5,000 beds across its hospitals. It also operates a network of 115 clinics out of which 106 are situated in GCC with only 9 in India. It also operates a chain of 225 pharmacies in GCC. # In GCC, the company has operations in United Arab Emirates (UAE), Oman, Qatar and Kingdom of Saudi Arabia. #
- Market Cap ₹ 7,111 Cr.
- Current Price ₹ 142
- High / Low ₹ 180 / 78.0
- Stock P/E 40.8
- Book Value ₹ 64.0
- Dividend Yield 0.00 %
- ROCE 13.0 %
- ROE 15.2 %
- Face Value ₹ 10.0
Pros
- No pros found. Suggest something.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Tax rate seems low
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1,784 | 1,775 | 1,837 | 2,150 | 2,201 | 2,029 | 2,087 | 2,322 | 2,301 | 1,761 | 2,268 | 2,259 | |
1,521 | 1,651 | 1,712 | 1,891 | 1,851 | 1,806 | 1,842 | 1,937 | 1,897 | 1,618 | 1,997 | 1,931 | |
Operating Profit | 263 | 124 | 125 | 259 | 350 | 223 | 245 | 385 | 404 | 143 | 271 | 328 |
OPM % | 15% | 7% | 7% | 12% | 16% | 11% | 12% | 17% | 18% | 8% | 12% | 15% |
Other Income | 55 | 22 | 15 | 6 | 7 | 3 | 4 | -14 | 25 | 8 | 9 | 7 |
Interest | 47 | 40 | 39 | 56 | 55 | 88 | 88 | 71 | 112 | 80 | 75 | 62 |
Depreciation | 56 | 74 | 76 | 79 | 78 | 126 | 149 | 140 | 171 | 155 | 153 | 157 |
Profit before tax | 216 | 32 | 24 | 130 | 224 | 12 | 12 | 160 | 146 | -85 | 53 | 115 |
Tax % | 5% | 36% | 42% | 13% | 2% | 18% | 42% | 5% | -0% | -5% | 20% | 7% |
Net Profit | 190 | 12 | 11 | 100 | 209 | 3 | 3 | 139 | 131 | -83 | 33 | 92 |
EPS in Rs | 3.76 | 0.25 | 0.22 | 1.99 | 4.14 | 0.06 | 0.06 | 2.75 | 2.62 | -1.66 | 0.66 | 1.85 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|
1,922 | 2,871 | 3,876 | 5,250 | 5,931 | 6,721 | 7,963 | 8,738 | 8,589 | |
1,660 | 2,420 | 3,370 | 4,805 | 5,762 | 6,089 | 6,887 | 7,274 | 7,443 | |
Operating Profit | 261 | 451 | 506 | 445 | 169 | 632 | 1,075 | 1,465 | 1,146 |
OPM % | 14% | 16% | 13% | 8% | 3% | 9% | 14% | 17% | 13% |
Other Income | 11 | 18 | 23 | 25 | 633 | 177 | -154 | -158 | 49 |
Interest | 45 | 48 | 79 | 189 | 371 | 204 | 205 | 391 | 329 |
Depreciation | 76 | 111 | 144 | 243 | 322 | 298 | 306 | 586 | 636 |
Profit before tax | 151 | 310 | 306 | 38 | 108 | 308 | 410 | 330 | 229 |
Tax % | 4% | 9% | 11% | 78% | 10% | 8% | 10% | 5% | |
Net Profit | 92 | 178 | 272 | 8 | 102 | 269 | 333 | 277 | 173 |
EPS in Rs | 7.26 | 4.69 | 7.00 | 0.20 | 2.52 | 5.32 | 6.59 | 5.54 | 3.47 |
Dividend Payout % | 0% | 35% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 14% |
TTM: | -1% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 50% |
TTM: | -53% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -6% |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 8% |
3 Years: | 15% |
Last Year: | 15% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|
125 | 375 | 389 | 403 | 403 | 505 | 505 | 500 | 500 | |
Reserves | 654 | 536 | 1,096 | 17 | 1,034 | 1,952 | 2,334 | 2,398 | 2,697 |
Borrowings | 505 | 886 | 1,091 | 3,321 | 2,758 | 2,352 | 2,788 | 5,605 | 4,858 |
856 | 1,097 | 1,834 | 2,003 | 2,609 | 2,670 | 3,300 | 3,903 | 4,057 | |
Total Liabilities | 2,140 | 2,894 | 4,409 | 5,743 | 6,804 | 7,479 | 8,928 | 12,405 | 12,112 |
872 | 1,087 | 2,237 | 2,507 | 3,520 | 3,738 | 4,289 | 7,124 | 6,866 | |
CWIP | 185 | 357 | 197 | 358 | 290 | 402 | 550 | 736 | 885 |
Investments | 6 | 7 | 3 | 39 | 32 | 38 | 22 | 34 | 50 |
1,077 | 1,442 | 1,972 | 2,839 | 2,962 | 3,302 | 4,067 | 4,511 | 4,311 | |
Total Assets | 2,140 | 2,894 | 4,409 | 5,743 | 6,804 | 7,479 | 8,928 | 12,405 | 12,112 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|
236 | 203 | 361 | 537 | 601 | 1,223 | |||
-439 | -775 | -1,136 | -522 | -702 | -658 | |||
203 | 578 | 654 | 46 | 134 | -675 | |||
Net Cash Flow | -1 | 5 | -122 | 61 | 33 | -110 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|
ROCE % | 23% | 18% | 7% | 2% | 8% | 15% | 13% | |
Debtor Days | 95 | 86 | 83 | 93 | 79 | 84 | 93 | 99 |
Inventory Turnover | 5.92 | 4.98 | 4.66 | 4.19 | 3.72 | 3.71 | 3.25 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 1 Mar
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 24 Feb
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 18 Feb
- Intimation Of Modification To The ESOP Trust Deed 13 Feb
- Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Relating To Consolidation Of Pharmacies And Clinics Operating In The GCC 10 Feb
View all